Takip et
Robert B Campbell
Robert B Campbell
Professor of pharmaceutics, MCPHS University, Department of Pharmaceutical Sciences, Worcester, MA
mcphs.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Role of tumor–host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors
A Pluen, Y Boucher, S Ramanujan, TD McKee, T Gohongi, E Di Tomaso, ...
Proceedings of the National Academy of Sciences 98 (8), 4628-4633, 2001
7322001
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy
EB Brown, RB Campbell, Y Tsuzuki, L Xu, P Carmeliet, D Fukumura, ...
Nature medicine 7 (7), 864-868, 2001
7312001
Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors
RB Campbell, D Fukumura, EB Brown, LM Mazzola, Y Izumi, RK Jain, ...
Cancer research 62 (23), 6831-6836, 2002
4802002
Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors
G Alexandrakis, EB Brown, RT Tong, TD McKee, RB Campbell, ...
Nature medicine 10 (2), 203-207, 2004
2172004
Influence of cationic lipids on the stability and membrane properties of paclitaxel‐containing liposomes
RB Campbell, SV Balasubramanian, RM Straubinger
Journal of pharmaceutical sciences 90 (8), 1091-1105, 2001
1552001
The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting
S Dandamudi, RB Campbell
Biomaterials 28 (31), 4673-4683, 2007
1542007
PTEN enters the nucleus by diffusion
F Liu, S Wagner, RB Campbell, JA Nickerson, CA Schiffer, AH Ross
Journal of cellular biochemistry 96 (2), 221-234, 2005
1432005
Tumor physiology and delivery of nanopharmaceuticals
RB Campbell
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2006
1412006
Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations
MM Migliore, TK Vyas, RB Campbell, MM Amiji, BL Waszczak
Journal of pharmaceutical sciences 99 (4), 1745-1761, 2010
1332010
Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties
RB Campbell, SV Balasubramanian, RM Straubinger
Biochimica et Biophysica Acta (BBA)-Biomembranes 1512 (1), 27-39, 2001
1332001
Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics
RB Campbell, B Ying, GM Kuesters, R Hemphill
Journal of pharmaceutical sciences 98 (2), 411-429, 2009
1282009
Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease
MM Migliore, R Ortiz, S Dye, RB Campbell, MM Amiji, BL Waszczak
Neuroscience 274, 11-23, 2014
1132014
Drug delivery formulations and targeting
RB Campbell, RK Jain
US Patent 6,680,068, 2004
862004
Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature
S Dandamudi, RB Campbell
Biochimica et Biophysica Acta (BBA)-Biomembranes 1768 (3), 427-438, 2007
852007
Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain
AV Kalra, RB Campbell
British journal of cancer 97 (7), 910-918, 2007
702007
Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential
GM Kuesters, RB Campbell
Nanomedicine 5 (2), 181-192, 2010
662010
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours
AV Kalra, RB Campbell
European Journal of Cancer 45 (1), 164-173, 2009
652009
Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and …
S Dabbas, RR Kaushik, S Dandamudi, GM Kuesters, RB Campbell
Endothelium 15 (4), 189-201, 2008
632008
Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat
RB Campbell
Future Medicine Ltd 2 (5), 649-652, 2007
622007
Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting
AV Kalra, RB Campbell
Pharmaceutical research 23, 2809-2817, 2006
552006
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20